Clin2
NCT07665931Possibly a fitRecruiting

Testing Simeox for severe COPD with lung hyperinflation

Chronic Obstructive Pulmonary Disease (COPD)Pulmonary Hyperinflation

Part of Lungs & breathing clinical trials.

This trial tests if a device called Simeox can reduce trapped air in the lungs of people with severe COPD. It may help you breathe easier if you have pulmonary hyperinflation.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
23 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 or older
  • You must have severe or very severe COPD (GOLD stage 3 or 4)
  • You must have documented lung hyperinflation (higher trapped air than normal)
  • You must be stable (no flare-ups in the last 3 weeks)
  • You cannot have recent lung collapse, active bleeding in the lungs, unstable heart problems, or serious muscle weakness
  • You must be able to give written consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06956742Recruiting
Breathing device study for COPD shortness of breath after exercise

This trial tests a device that briefly opens your airways to help release trapped air after exercise. It may reduce shortness of breath and improve your daily life with COPD.

Rouen, Normandy
NCT07125989Not yet recruiting
Breathing support during exercise for severe COPD

This trial tests whether a special breathing device that helps you breathe during exercise can help you walk or pedal longer without getting out of breath. It is for people with severe COPD who have high carbon dioxide levels in their blood or who get very tired during exercise.

Saint-Etienne
NCT07382258Recruiting
Inhaled nitric oxide for COPD: a clinical study

This trial tests whether a gas called nitric oxide, breathed in through the nose or mouth, can help people with moderate to severe COPD. It could improve breathing and quality of life.

Nanjing, Jiangsu
NCT06801327Recruiting
Comparing two breathing therapies for bronchiectasis

This trial tests whether a new device called Simeox works better than standard chest physical therapy for people with bronchiectasis (widened airways that trap mucus). It compares how well each method clears mucus from the lungs.

Bologna, Bologna
NCT07443124Not yet recruiting
Simeox 200 for mucus clearance in bronchiectasis

This study is testing a new device called Simeox 200 to help clear mucus from your lungs. If you have bronchiectasis and produce a lot of mucus daily, this device might make it easier to breathe and reduce lung infections.

Charleston, South Carolina
NCT06487273Recruiting
SIMEOX device for mucus clearance at home in bronchiectasis

This study tests a home-use device called SIMEOX, which helps clear mucus from your lungs. It is for adults with bronchiectasis (not cystic fibrosis) who have frequent lung infections.

Abbeville

Hear when a new Chronic Obstructive Pulmonary Disease (COPD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.